Molecular Models of <em>Toxoplasma gondii</em> in Humans and Animals
PDF
Cite
Share
Request
Review
P: 128-132
June 2024

Molecular Models of Toxoplasma gondii in Humans and Animals

Turkiye Parazitol Derg 2024;48(2):128-132
No information available.
No information available
Received Date: 25.09.2023
Accepted Date: 25.05.2024
PDF
Cite
Share
Request

ABSTRACT

Toxoplasma gondii (T. gondii) is an obligate intracellular, zoonotic protozoan parasite of interest to physicians and veterinarians with its highly complex structure. It is known to infect about one-third of the world’s population. Since it is a zoonotic disease, it is necessary to keep the animal population under control in order to prevent human exposure. Many studies have been conducted on the detection of T. gondii and it has been determined that there are three clonal groups consisting of types 1, 2, 3. Developments in molecular studies have led to changes in the taxonomy and new developments in parasitic diseases. It has helped in diagnosis, treatment, development of antiparasitic drugs and research on resistance. They also provided research on vaccine studies, genetic typing and phylogenetics of parasitic diseases. Conventional polymerase chain reaction (PCR), real-time PCR and genotyping studies conducted today increase our knowledge about T. gondii. Methods such as B1, SAG1, SAG2, GRA1, 529-bprepeat element, OWP genes and 18S rRNAs are mostly used in PCR, and methods such as MS, MLST, PCR-RFLP, RAPD-PCR and HRM are used in genotyping. Toxoplasmosis is a disease that is within the framework of the concept of one health and must attract attention, has not yet been eradicated in the world and needs joint studies for humans, animals and ecosystems to be eradicated. This can only be possible by establishing interdisciplinary groups, conducting surveys and training.

References

1
Milne G, Webster JP, Walker M.Toxoplasma gondii: an underestimated threat? Trends Parasitol. 2020; 36: 959-69.
2
Babur C, Yücesan B, Sezen F, Kılıç S. Evaluation of Seropositivity of Toxoplasmosis Suspected Patients Admitted to the National Parasitology Reference Laboratory Between 2009 and 2019. Turkiye Parazitol Derg. 2021; 45: 181-9.
3
Zhao XY, Ewald SE. The molecular biology and immune control of chronicToxoplasma gondii infection. J Clin Invest. 2020; 130: 3370-80.
4
Lourido S.Toxoplasma gondii. Trends Parasitol. 2019; 35: 944-5.
5
Sanchez SG, Besteiro S. The pathogenicity and virulence ofToxoplasma gondii. Virulence. 2021; 12: 3095-114.
6
Yücesan B, Babur C, Koç N, Sezen F, Kılıç S, Gürüz Y. Investigation of anti-Toxoplasma gondii antibodies in cats using Sabin-Feldman dye test in Ankara in 2016. Turkiye Parazitol Derg. 2019; 43: 5-9.
7
Djurković-Djaković O, Dupouy-Camet J, Van der Giessen J, Dubey JP. Toxoplasmosis: overview from a one health perspective. Food Waterborne Parasitol. 2019; 15: e00054.
8
Kolören Z, Dubey J. A review of toxoplasmosis in humans and animals in Turkey. Parasitology. 2020; 147: 12-28.
9
Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing ofToxoplasma gondii. Parasit Vectors. 2015; 8: 292.
10
Howe DK, Sibley LD.Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995; 172: 1561-6.
11
Dardé ML. Genetic analysis of the diversity inToxoplasma gondii. Ann Ist Super Sanita. 2004; 40: 57-63.
12
Döşkaya M, Caner A, Ajzenberg D, Değirmenci A, Dardé ML, Can H, et al. Isolation ofToxoplasma gondii strains similar to Africa 1 genotype in Turkey. Parasitol Int. 2013; 62: 471-4.
13
Gasser RB. Molecular tools—advances, opportunities and prospects. Vet Parasitol. 2006; 136: 69-89.
14
Bişkin Z, Yıldırım A, İnci A, Düzlü Ö. Molecular Biological Techniques used for Diagnosis in Parasitology. J Fac Vet Med Univ Erciyes. 2011; 8: 43-51.
15
Tunçbilek S. Toksoplazmoz Tanısında Polimeraz Zincir Reaksiyonunun Yeri. Türk Hij Den Biyol Derg. 2000; 57: 195-202.
16
Burg JL, Grover CM, Pouletty P, Boothroyd J. Direct and sensitive detection of a pathogenic protozoan,Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989; 27: 1787-92.
17
Calderaro A, Piccolo G, Gorrini C, Peruzzi S, Zerbini L, Bommezzadri S, et al. Comparison between two real-time PCR assays and a nested-PCR for the detection ofToxoplasma gondii. Acta Biom. 2006; 77: 75-80.
18
Gürüz AY, Özcel MA. Toxoplasmosis. İçinde: Özcel MA editör. Tıbbi Parazit Hastalıkları. Meta Basım. İzmir: Bornova; 2007. s.141-187.
19
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000; 28: E63.
20
Yücesan B, Özkan Ö. SudaToxoplasma gondii analizi ve yeni bir yaklaşım: İlmiğe Dayalı İzotermal Amplifikasyon tekniği. Eurosian JHS. 2018; 1: 30-7.
21
Yucesan B, Guldemir D, Babur C, Kilic S, Cakmak A. Whole-genome sequencing of aToxoplasma gondii strain from a Turkish isolate using next-generation sequencing technology. Acta Tropica. 2021; 218: 105907.
22
NCBI (National Center for biotechnology Information) Access time: 26.08.2023. Available from:https://www.ncbi.nlm.nih.gov/datasets/genome/?taxon=5811.
23
Ho-Yen D, Joss A, Balfour A, Smyth E, Baird D, Chatterton J. Use of the polymerase chain reaction to detectToxoplasma gondii in human blood samples. J Clin Pathol. 1992; 45: 910-3.
24
UMS (Ulusal Mikrobiyoloji Standartları Bulaşıcı Hastalıklar Laboratuvar Tanı Rehberi)- Parazitoloji/Mikrobiyolojik Tanımlama/P-MT-08/Sürüm:1-1/01.01.2015 Editör: Akbaş E, Yardımcı Editörler: Abacıoğlu H, Otgun SN, Ankara-2015, ISBN: 978-975-590-489-4, Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No: 934.
25
Kompalic-Cristo A, Frotta C, Suárez-Mutis M, Fernandes O, Britto C. Evaluation of a real-time PCR assay based on the repetitive B1 gene for the detection ofToxoplasma gondii in human peripheral blood. Parasitol Res. 2007;101:619-25.
26
Valian HK, Mirhendi H, Mohebali M, Shojaee S, Fallahi S, Jafari R, et al. Comparison of the RE-529 sequence and B1 gene for Toxoplasma gondii detection in blood samples of the at-risk seropositive cases using uracil DNA glycosylase supplemented loop-mediated isothermal amplification (UDG-LAMP) assay. Microb Pathog. 2020; 140: 103938.
27
Guy EC, Joynson DH. Potential of the polymerase chain reaction in the diagnosis of activeToxoplasma infection by detection of parasite in blood. J Infec Dis. 1995; 172: 319-22.
28
Tavassoli M, Ghorbanzadehghan M, Esmaeilnejad B. Foll Detection ofToxoplasma gondii in sheep and goats blood samples by PCR-RFLP in Urmia. Vet Res Forum. 2013; 4: 43-7.
29
Aguirre AA, Basu N, Kahn LH, Morin XK, Echaubard P, Wilcox BA, et al. Transdisciplinary and social-ecological health frameworks—Novel approaches to emerging parasitic and vector-borne diseases. Parasite Epidemiol Control. 2019; 4: e00084.
30
Sağlık Bakanlığı Türkiye Zoonotik Hastalıklar Eylem Planı (2019-2023). Erişim adresi:https://ekutuphane.saglik.gov.tr/Yayin/564. Erişim tarihi: 21.04.2024
31
Wang ZD, Wang SC, Liu HH, Ma HY, Li ZY, Wei F, et al. Prevalence and burden ofToxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017; 4: e177-e88.
32
Khan IA, Moretto M. Immune responses toToxoplasma gondii. Curr Opin Immunol. 2022; 77: 102226.
33
Kurtoğlu E, Hidayetoglu T. Akut Lenfoblastik Lösemili Hastada Gelişen ve Ampirik Yaklaşımla Tedavi Edilen Multipl Odaklı Beyin Apsesi Olgusu. Fırat Tıp Dergisi. 2004; 9: 59-61.